Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: RNA-Loaded Dendritic Cell Cancer Vaccine [Phase 1, Phase 2]
Clinical trial update indicates completion of a Phase 1/Phase 2 study evaluating an RNA-loaded dendritic cell cancer vaccine for renal cell …
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of temsirolimus and bevacizumab for metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain [Phase 2]
Phase 2 clinical trial update evaluating sorafenib for patients with metastatic renal cell carcinoma that has spread to the brain. The study…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating bryostatin-1 in metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Phase 2 Study in Patients With MiT Tumors [Phase 2]
Phase 2 study of tivantinib in MiT family tumors including renal cell carcinoma, alveolar soft part sarcoma, and clear cell sarcoma has been…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer [Phase 2]
Phase 2 trial update of interleukin-2 and bryostatin-1 in patients with advanced renal cell carcinoma; the study is completed.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment [Phase 2]
Phase 2 trial of Semaxanib (SU5416) for metastatic renal cell carcinoma that failed prior therapy was terminated. This document serves as a …
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer [Phase 2]
A phase 2 clinical trial evaluating lenalidomide in patients with advanced or unresectable kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer [Phase 2]
A Phase 2 trial of carboxyamidotriazole for metastatic renal cell carcinoma (recurrent or stage IV) conducted by the National Cancer Institu…
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib [Phase 3]
Phase 3 trial comparing everolimus plus best supportive care versus placebo plus best supportive care in metastatic renal cell carcinoma tha…
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib [Phase 2]
A Phase 2 study of ABT-869 (linifanib) in advanced renal cell carcinoma following prior sunitinib treatment has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma [Phase 2]
Phase 2 trial of doxorubicin and gemcitabine in locally recurrent or unresectable metastatic renal cell carcinoma (including sarcomatoid fea…
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating sorafenib in patients undergoing surgery for metastatic kidney cancer was terminated; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma [Phase 4]
Phase 4 trial assessing safety and efficacy of sunitinib malate as first-line therapy in Chinese patients with metastatic renal cell carcino…
-
CLINICAL_TRIALS trial_result · 2012-12-12Clinical Trial Update: A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer [Phase 1]
This first-in-human Phase 1 study evaluates the safety of multiple dose levels of AGS-16M8F in patients with advanced renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer [Phase 2]
Phase II study evaluating Aldesleukin (IL-2) after Zanolimumab in metastatic melanoma and metastatic renal cell carcinoma was terminated, wi…
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: LBH589 Treatment for Refractory Clear Cell Renal Carcinoma [Phase 2]
Phase 2 trial update for LBH589 in refractory clear cell renal carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: A Phase II Uncontrolled Study of BAY73-4506 in Previously Untreated Patients With Metastatic or Unresectable RCC [Phase 2]
Phase II trial of BAY73-4506 in previously untreated metastatic or unresectable renal cell carcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
This clinical trial evaluated non-myeloablative allogeneic stem cell transplantation with matched unrelated donors across several hematologi…
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Study In Patients With Kidney Cancer Treated With Sutent
A completed clinical trial evaluated Sutent (sunitinib) in patients with advanced or metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer [Phase 2]
Phase 2 trial S0312 evaluating gemcitabine plus capecitabine in patients with advanced renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma [Phase 3]
A Phase 3 trial evaluating interferon plus temsirolimus (CCI-779) in advanced renal cell carcinoma has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer [Phase 1]
A Phase 1 trial of Interleukin-7 in patients with metastatic melanoma or renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-10-12Clinical Trial Update: Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer [Phase 2]
Phase 2 study evaluating tariquidar with docetaxel in patients with lung cancer, ovarian cancer, cervical cancer, and renal cell carcinoma. …
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Vaccine Treatment of Kidney Cancer [Phase 2]
A Phase 2 clinical trial of a kidney cancer vaccine sponsored by the National Cancer Institute was terminated, with results posted in 2012.